About
CNS drugs
Areas of Focus
Categories
Small Molecule PharmaceuticalMiddle East
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
14
As Collaborator
3
Total Enrollment
2,324
By Phase
PHASE2/PHASE3: 1PHASE3: 5PHASE2: 7PHASE1: 2PHASE4: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 13ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05267535Lead Sponsor
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
PHASE2/PHASE3Active, not recruiting
225 participants
Started: May 12, 2022 · Completed: Jun 30, 2025
NCT04233502Lead Sponsor
Efficacy and Safety of Slenyto for Insomnia in Children With ASD
PHASE3Withdrawn
Started: Sep 30, 2020 · Completed: Dec 31, 2022
NCT02615002Lead Sponsor
Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
PHASE2Completed
371 participants
Started: Nov 30, 2015 · Completed: Nov 19, 2019
NCT01906866Lead Sponsor
Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
PHASE3Completed
125 participants
Started: Oct 31, 2013 · Completed: Mar 27, 2018
NCT02087722Collaborator
Efficacy and Safety of KI1001 in the Treatment of ≥ 55 Years Old Insomnia Patients
PHASE3Completed
80 participants
Started: Aug 31, 2013 · Completed: Jan 31, 2014
Locations (1)
Headquarters
Tel Aviv, Israel
Map
Loading map...